Analysts Suggest Pfizer Takes Over GSK; GSK Remains Doubtful

Source: Bloomberg

May 21, 2015

A Deutsche Bank AG analyst has proposed the idea of “PfizerKline” -- Pfizer taking over U.K. rival GlaxoSmithKline, but Pfizer has not confirmed interest yet.

Anticipating government resistance, GSK's broker, Citigroup said, “We doubt that GSK is a viable acquisition target for Pfizer."

But Pfizer CEO Ian Read has indicated he's looking for transactions that can pump up the biggest U.S. drugmaker’s sales. Pfizer announced a $17B acquisition of Hospira in February. Last May, the drugmaker gave up on a potential $117B takeover of AstraZeneca which, according to Pfizer CFO, failed because of price.

Read the Bloomberg article


Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments